Revision history of "Study PHASE I/IIa, PROSPECTIVE, Randomised AND DOUBLE CIEGO ON SECURITY AND EFICACE OF nebulised liposomal amphotericin as COADYUVANT TREATMENT OF INVASIVE PULMONARY ASPERGILOSIS" (Q3171483)

9 October 2024

• curprev 10:4510:45, 9 October 2024‎ DG Regio talk contribs‎ 78,327 bytes +4‎ ‎Changed label, description and/or aliases in pt
• curprev 10:4510:45, 9 October 2024‎ DG Regio talk contribs‎ 78,323 bytes +7‎ ‎Set a claim value: summary (P836): O objetivo é avaliar a segurança e eficácia da anfotericina B lipossómica nebulizada (ALN) como terapêutica complementar ao tratamento sistémico habitual em doentes com aspergilose pulmonar invasiva e a utilidade de um teste não rotineiro como marcador de eficácia de gestação de substituição. Para o efeito, será realizado um ensaio clínico de fase I/IIa de 3 anos num ensaio monocêntrico, prospetivo, aleatorizado e em dupla ocultação em doentes com a...

22 March 2024

• curprev 17:1917:19, 22 March 2024‎ DG Regio talk contribs‎ 78,316 bytes +288‎ ‎Added qualifier: readability score (P590521): 0.9136811236865356

20 December 2023

• curprev 17:1017:10, 20 December 2023‎ DG Regio talk contribs‎ 78,028 bytes +7‎ ‎Changed an Item

12 June 2023

• curprev 14:1214:12, 12 June 2023‎ DG Regio talk contribs‎ 78,021 bytes +540‎ ‎Changed an Item

10 June 2023

• curprev 06:4806:48, 10 June 2023‎ Admin talk contribs‎ 77,481 bytes +437‎ BatchIngestion

18 August 2022

• curprev 03:0603:06, 18 August 2022‎ DG Regio talk contribs‎ 77,044 bytes +53,278‎ ‎Changed label, description and/or aliases in el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl, nl, fr, de, it, es, and other parts: Adding translations: el, da, fi, mt, lv, sk, ga, cs, pt, et, hu, bg, lt, hr, sv, ro, sl, pl,

16 January 2022

• curprev 14:0514:05, 16 January 2022‎ DG Regio talk contribs‎ 23,766 bytes +2,682‎ ‎Changed label, description and/or aliases in it, and other parts: Adding Italian translations

17 December 2021

• curprev 15:2915:29, 17 December 2021‎ DG Regio talk contribs‎ 21,084 bytes +2,729‎ ‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations

9 December 2021

• curprev 14:0014:00, 9 December 2021‎ DG Regio talk contribs‎ 18,355 bytes +2,721‎ ‎Changed label, description and/or aliases in de, and other parts: Adding German translations

4 December 2021

• curprev 13:1513:15, 4 December 2021‎ DG Regio talk contribs‎ 15,634 bytes +2,931‎ ‎Changed label, description and/or aliases in fr, and other parts: Adding French translations

12 October 2021

• curprev 18:1818:18, 12 October 2021‎ DG Regio talk contribs‎ 12,703 bytes +2,293‎ ‎Created claim: summary (P836): The aim is to assess the safety and efficacy of nebulised liposomal amphotericin B (ALN) as complementary therapy to the usual systemic treatment in patients with invasive pulmonary aspergillosis and the usefulness of a non-routine test as a surrogacy marker of efficacy. To this end, a 3-year phase I/IIa clinical trial will be conducted in a single-centre, prospective, randomised, and double-blind trial in patients with proven or likely pulmonar...
• curprev 18:1818:18, 12 October 2021‎ DG Regio talk contribs‎ 10,410 bytes −2,293‎ ‎Removed claim: summary (P836): The aim is to assess the safety and efficacy of nebulised liposomal amphotericin B (ALN) as complementary therapy to the usual systemic treatment in patients with invasive pulmonary aspergillosis and the usefulness of a non-routine test as a surrogacy marker of efficacy. To this end, a 3-year phase I/IIa clinical trial will be conducted in a single-centre, prospective, randomised, and double-blind trial in patients with proven or likely pulmon...
• curprev 17:5917:59, 12 October 2021‎ DG Regio talk contribs‎ 12,703 bytes +238‎ ‎Changed label, description and/or aliases in en: translated_label
• curprev 17:5917:59, 12 October 2021‎ DG Regio talk contribs‎ 12,465 bytes +2,293‎ ‎Created claim: summary (P836): The aim is to assess the safety and efficacy of nebulised liposomal amphotericin B (ALN) as complementary therapy to the usual systemic treatment in patients with invasive pulmonary aspergillosis and the usefulness of a non-routine test as a surrogacy marker of efficacy. To this end, a 3-year phase I/IIa clinical trial will be conducted in a single-centre, prospective, randomised, and double-blind trial in patients with proven or likely pulmonar...

10 October 2021

• curprev 19:0719:07, 10 October 2021‎ DG Regio talk contribs‎ 10,172 bytes +427‎ ‎Changed an Item: Edited by the materialized bot - inferring region from the coordinates

9 October 2021

• curprev 14:5314:53, 9 October 2021‎ DG Regio talk contribs‎ 9,745 bytes +499‎ ‎Changed an Item: Edited by the infer coords bot - inferring coordinates from location

8 October 2021

• curprev 09:3209:32, 8 October 2021‎ DG Regio talk contribs‎ 9,246 bytes −10‎ ‎Changed label, description and/or aliases in en
• curprev 09:3209:32, 8 October 2021‎ DG Regio talk contribs‎ 9,256 bytes +9,256‎ ‎Created a new Item